Be'er Sheva, Israel
DiA Imaging Analysis
Ultrasound is a critical tool for clinical diagnosis used to evaluate the structure and function of human organs. Millions of ultrasound exams are performed annually, but most are conducted and analyzed by humans in a manual process that is subjective, time consuming and highly dependent on the provider’s experience—or lack thereof. DiA’s AI-powered ultrasound analysis solutions automate the ultrasound process, improving efficiency and accuracy. The company’s LVivo suite captures the necessary images and automatically identifies clinical abnormalities in heart function. (The technology works by imitating the way the human eye identifies borders and motion to detect patterns in real time, enabling it to generate consistent, reliable and reproducible analyses.) DiA’s proprietary AI was trained on a database of hundreds of thousands of images and in collaboration with leading medical centers, including Mount Sinai, Yale and RUSH. The company’s cross-platform solutions are vendor-neutral and can provide end-user support on any ultrasound device or IT/PACS system.
The Support and Resources
- $1.5 million equity investment; CI led the round with Defta Healthcare, and other investors joined in
- CI’s Peter Longo joined DiA’s board
- Introductions to investors and industry connections, including leading medical centers in Connecticut
- Help finding employees and local service providers for public relations, recruiting, and financial and legal consulting
- Press release coordination
Today, DiA Imaging Analysis is the leading provider of AI-powered ultrasound analysis solutions in the world. Based in Israel and in Rocky Hill, Connecticut, the company continues to transform the way clinicians capture and analyze ultrasound images to guide their decisions, most recently on the frontlines of the COVID-19 crisis, where the use of cardiac ultrasound for patient triage and monitoring has proven crucial. The company has 20 full-time employees and has raised more than $12.5 million in investment capital. Its LVivo AI solutions are distributed through eight channel partnerships with industry-leading ultrasound vendors, including GE Healthcare, Konica Minolta and IBM Watson, and are serving thousands of hospitals, clinics and clinicians worldwide. The company has several FDA and CE-cleared products. Additional approvals are pending.